Is CNQQF or MRK a better dividend investment in 2026?

CNQQF currently yields 470.59% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CNQQF offers higher current income.

What is the dividend yield difference between CNQQF and MRK?

CNQQF has a forward dividend yield of 470.59% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 467.83 percentage points.

Home › Compare › CNQQF vs MRK

CNQQF vs MRK: Dividend Comparison 2026

CNQQF yields 470.59% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CNQQF wins by $38545.06M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CNQQF

● Live price

470.59%

Share price

$0.43

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$38545.12M

Annual income

$27,182,357,871.92

Full CNQQF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CNQQF vs MRK

📍 CNQQF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CNQQF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CNQQF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CNQQF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNQQF

Annual income on $10K today (after 15% tax)

$40,000.00/yr

After 10yr DRIP, annual income (after tax)

$23,105,004,191.13/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CNQQF beats the other by $23,104,995,862.72/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNQQF + MRK for your $10,000?

CNQQF: 50%MRK: 50%

100% MRK50/50100% CNQQF

Portfolio after 10yr

$19272.59M

Annual income

$13,591,183,835.03/yr

Blended yield

70.52%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CNQQF

No analyst data

Altman Z

1.0

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNQQF buys

MRK buys

No recent congressional trades found for CNQQF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCNQQFMRK

Forward yield	470.59% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$38545.12M ✓	$56.8K
Annual income after 10y	$27,182,357,871.92 ✓	$9,798.13
Total dividends collected	$37542.88M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CNQQF vs MRK ($10,000, DRIP)

Year	CNQQF Portfolio	CNQQF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$57,759	$47,058.82	$11,206	$366.19	+$46.6K → CNQQF
2	$315,826	$254,024.51	$12,650	$502.35	+$303.2K → CNQQF
3	$1,636,076	$1,298,141.44	$14,407	$694.19	+$1.62M → CNQQF
4	$8,035,425	$6,284,824.27	$16,585	$967.82	+$8.02M → CNQQF
5	$37,445,846	$28,847,941.19	$19,342	$1,363.89	+$37.43M → CNQQF
6	$165,706,448	$125,639,392.36	$22,913	$1,947.19	+$165.68M → CNQQF
7	$696,916,266	$519,610,366.98	$27,662	$2,823.89	+$696.89M → CNQQF
8	$2,788,074,169	$2,042,373,764.24	$34,159	$4,173.35	+$2788.04M → CNQQF
9	$10,619,401,952	$7,636,162,591.12	$43,337	$6,308.80	+$10619.36M → CNQQF
10	$38,545,117,961	$27,182,357,871.92	$56,776	$9,798.13	+$38545.06M → CNQQF

CNQQF vs MRK: Complete Analysis 2026

CNQQF — Stock

Clean TeQ Water Limited provides metals recovery and water treatment solutions for governments and companies. The company offers technology solutions in the areas of continuous ionic filtration, membrane free desalination, chemical free recovery reverse osmosis, encapsulated bacteria lenses, complete nitrate removal, low energy evaporation and crystallization, and metal recovery, as well as membranes for filtration of waters and wastewaters. It also undertakes turnkey projects, such as metals recovery and water treatment plants. The company serves municipal wastewater, surface water, industrial wastewater, and mining wastewater sectors. Clean TeQ Water Limited was incorporated in 2021 and is headquartered in Notting Hill, Australia.

Full CNQQF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CNQQF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNQQF vs SCHD CNQQF vs JEPI CNQQF vs O CNQQF vs KO CNQQF vs MAIN CNQQF vs JNJ CNQQF vs ABBV CNQQF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.